Clinical Trial Update: Investigation Of A New Medication (GW642444) In Asthmatic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of GW642444 in asthmatic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW642444 (GW642444)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED